Immediate Impact

1 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
22 intermediate papers

Works of Michael G. Currier being referenced

EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression
2016
The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection
2013
and 4 more

Author Peers

Author Last Decade Papers Cites
Michael G. Currier 394 57 196 170 9 452
G. A. Prince 342 53 118 188 10 391
L T Pierik 326 38 129 153 10 376
Lois Ann Shearer 447 34 169 238 5 509
Kelsey A. Gaston 394 48 204 134 7 443
Luis Velozo 409 71 217 112 7 480
Veronica Hulstrøm 385 27 123 178 16 448
Elaine M. Castilow 299 46 164 130 10 463
Mariska E. A. van Dijk 227 29 118 91 7 399
Samuel Z. Wilson 358 55 198 170 13 493
Helen Bright 272 27 140 91 14 467

All Works

Loading papers...

Rankless by CCL
2026